cognitive cybersecurity intelligence

News and Analysis

Search

Is the HIF-PHI class of next-generation kidney drugs doomed in the U.S.?

The FDA’s recent complete response letter (CRL) for vadadustat — an oral therapy evaluated for the treatment of anemia in patients with chronic kidney disease (CKD) — was a big surprise and disappointment for our community. The trials had quite convincingly demonstrated efficacy as…

Source: medcitynews.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts